Navigation Links
Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings

News of interest for post menopausal women with breast cancer positive to hormone receptors and HER2 -addition of both Herceptin (trastuzumab) from Roche// and Arimidex (anastrozole) from AstraZeneca to their treatment improves the length of progression free time by 4.8 months.

A Phase III clinical trial sponsored by Roche showed that Arimidex alone inhibited the progression by just 2.4 months after which the cancer continued to progress.

Hormone sensitive breast cancer is seen in 66% of postmenopausal breast cancer and 25% are HER2 positive. The cancer is therefore a very aggressive form and the chances of relapse are higher.

Roche had already announced in May that the Herceptin-Arimidex combination was proving to be particularly effective. It announced the full findings on Monday in Istanbul at the European Society for Medical Oncology Congress.

Dr. Bella Kaufman, from Israel's Chaim Sheba Medical Centre, who had led the trial, said the findings were extremely positive, as double progression free survival is rare in breast cancer trials.

The trial also showed that overall survival was also prolonged to an average of 28.5 months. However this is not considered statistically significant since patients on Arimidex alone have their survival prolonged to 23.9 months.

Additional data showed that introducing anastrozole instead of Tamoxifen in early hormone sensitive breast cancer among postmenopausal women increased their chances of avoiding disease recurrence.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Drug Combo Works Better for children with ADHD, Tics
2. Scanning Combo Helps Detect Lung Cancer
3. Relief From Asthma With New Combo Therapy
4. Calcium-Vitamin D Combo For Reduced Fracture Risk
5. Drug Combo Improves Performance Of Multiple Sclerosis Drug
6. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
7. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
8. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
9. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
10. Fuzeon and MK-0518 Combo Holds Promise For HIV
11. Germ - Chemo Combo Fights Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... 2016 , ... The PAINWeekEnd Regional Conference will be hosted ... Honolulu, offering local frontline clinicians the opportunity to extend their certified continuing medical ... supplemental training related to pain management has surged dramatically in recent years, with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The ... how this current generation fits into Bible Prophecy. Yisrayl says this generation, known as ... to this conclusion, showing how the details line up exactly with Bible Prophecy – ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... ... and pharmaceutical organizations to build intelligent, connected applications, was named the best Sales ... , The winner announcement was made today by the Software & Information ...
(Date:11/30/2016)... Northridge, CA (PRWEB) , ... November 30, 2016 ... ... Elyson, announce that they now offer a comprehensive in-house dental plan for all ... dentists have developed a plan that gives patients a number of perks, including ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center ... has announced the opening of a new residential mental health treatment program in ... health issues such as severe anxiety, depression, bi-polar disorder, and other related issues. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 1, 2016  Today, Simpson Healthcare Executives, a global ... being selected as winners of multiple awards at the ... at the PLATINUM level, Blue Zones Menu at the ... GOLD Level, and our proprietary 3ConneX Platform at the ... Executives, we are excited to showcase our new Platinum ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
(Date:12/2/2016)... 2, 2016 Allergan plc (NYSE: AGN ... on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a variable ... Company will repurchase $10 billion of its ordinary shares. Approximately ...
Breaking Medicine Technology: